ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0613

Modeling the Effects of Covid-19 Protective Behaviors and Healthcare Delivery on the Health of Patients with Rheumatic Disease

Kevin Kennedy1, Emily Sirotich2, Salman Surangiwala3, Maggie Larche2, Mitchell Levine1 and Jonathan Hausmann4, 1McMaster University, Hamilton, Canada, 2McMaster University, Hamilton, ON, Canada, 3Queen’s School of Medicine, Kingston, Canada, 4Boston Children's Hospital / Beth Israel Deaconess Medical Center, Cambridge, MA

Meeting: ACR Convergence 2020

Keywords: COVID-19, Epidemiology, Health Services Research, Patient reported outcomes, Statistical methods

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 7, 2020

Title: Health Services Research Poster

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

COVID-19 has caused global disruptions in the management of chronic illnesses. The extent to which patients with rheumatic disease have been affected by COVID-19 and the related changes to methods of health service delivery is unknown. We present a model capturing the effects of the pandemic on the physical and mental health of a sample of adult patients with rheumatic disease.

Methods:

The COVID-19 Global Rheumatology Alliance Patient Experience Survey was disseminated online to patients with rheumatic disease. Patients reported age, gender, WHO region, employment status, ethnicity, change in employment status, smoking status, current rheumatic disease control, methods of communicating with rheumatologist, medications, possible exposure to COVID-19, COVID-19 diagnosis, hospitalization due to COVID-19, mental/physical health, and methods taken to protect from COVID-19, were entered in two multivariable regression models. The two models assessed the associations with the entered variables with PROMIS Global Health Mental and Global Health Physical scales.

Results:

Out of 9,393 patients, 1,544 were removed due to missingness. PROMIS Global Health Physical was associated with the additive independent predictors entered into the model with a large effect size (R2adj = 0.41, F = 123.744, 7804, p < 0.001). After adjusting for employment status, region, ethnicity, age, disease activity, smoking status, medications, and gender, patients unable to communicate with their rheumatologist reported a decreased physical health (-0.25, p < 0.001). Patients who quarantined, or those with COVID-19 diagnosis, experienced worse physical health (-0.18, p < 0.001; -0.21, p < 0.001). PROMIS Global Health Mental was associated with the independent predictors with a moderate effect size (R2adj = 0.27, F = 67.9444, 7804, p < 0.001). Patients who have not needed to communicate with their rheumatologist, were hospitalized with COVID-19, and had COVID-19 expressed better mental health (0.14, p = 0.022; 0.67, p < 0.01; 0.31, p < 0.01). Patients who identified possible contact with COVID-19 expressed a lower mental health state (0.15, p < 0.001).

Conclusion:

By modeling the effects of COVID-19 behaviors and health care service delivery, we demonstrated that patients unable to communicate with their rheumatologist, quarantined, and/or with COVID-19, experienced decreased physical health. In contrast, patients experienced better mental health if they reported no need to communicate with their rheumatologist, had COVID-19, and/or were hospitalized due to COVID-19.

It is evident that COVID-19 caused worse physical health, however, having or surviving COVID-19 paradoxically led to improved mental health. It is possible that these patients perceived a reduced mortality risk, despite the consequences to their physical health.

In contrast, patients who reported potential COVID-19 exposures endorsed poorer mental health, perhaps due to a greater perceived risk of mortality. Further exploration of patient characteristics and behaviors in a principal component analysis may provide additional insight into the experience of patients with rheumatic disease amidst a global pandemic.


Disclosure: K. Kennedy, Lyceum Health, 5; E. Sirotich, Canadian Arthritis Patient Alliance, 9; S. Surangiwala, None; M. Larche, AbbVie, 5, Amgen, 5, Boehringer-Ingelheim, 5, BMS, 5, Celgene, 5, Janssen, 5, Mallinckrodt, 5, Novartis, 5, Pfizer, 5, Roche, 5, Sandoz, 5, UCB, 5; M. Levine, None; J. Hausmann, Novartis, 5.

To cite this abstract in AMA style:

Kennedy K, Sirotich E, Surangiwala S, Larche M, Levine M, Hausmann J. Modeling the Effects of Covid-19 Protective Behaviors and Healthcare Delivery on the Health of Patients with Rheumatic Disease [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/modeling-the-effects-of-covid-19-protective-behaviors-and-healthcare-delivery-on-the-health-of-patients-with-rheumatic-disease/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/modeling-the-effects-of-covid-19-protective-behaviors-and-healthcare-delivery-on-the-health-of-patients-with-rheumatic-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology